Artwork

Conteúdo fornecido por Windrose Recovery. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por Windrose Recovery ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
Player FM - Aplicativo de podcast
Fique off-line com o app Player FM !

Therapy Unblinded: Inside MDMA Research

1:38:13
 
Compartilhar
 

Manage episode 425693814 series 2818467
Conteúdo fornecido por Windrose Recovery. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por Windrose Recovery ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.

Dr. Chantelle Thomas talks to Dr. Ingmar Gorman about concerns and methodological critiques of MDMA-assisted therapy, including historical boundary violations and inappropriate treatment of participants. They also address adverse event management, inner healing intelligence, and the importance of adapting language and approach to resonate with each individual participant. Additionally, they discuss the ethical complexities of conducting clinical trials, including balancing participant privacy and safety with the need to share information for public advocacy and education. Finally, they delve into the intricacies of trauma therapy, including personal experiences, clinical approaches, and limitations, and emphasize the need for a paradigm shift in clinical practice, prioritizing the client's agency and internal resources for healing.

(0:00:00) Introduction

(0:10:14) FDA's decision on MDMA therapy for PTSD, with focus on ICER and FDA advisory panel reports.

(0:15:21) The benefits and challenges of a clinical trial for treating PTSD.

(0:21:03) Conducting clinical trials with nuanced considerations for ethics, regulations, and participant experiences.

(0:31:52) Adverse events in the trial, with concerns about data accuracy and researcher bias.

(0:44:02) Suicidal ideation and its impact on mental health treatment.

(0:52:23) Clinical trial design and unblinding issues in PTSD treatment study.

(0:59:26) MDMA therapy for trauma, participants' experiences and criticisms.

(1:05:31) Trauma therapy effectiveness and the importance of considering other measures beyond PTSD symptoms.

(1:10:36) Inner healing intelligence in MDMA-assisted therapy.

(1:29:51) MDMA-assisted therapy for PTSD, including resourcing and adherence.

Dr. Chantelle Thomas, Executive Clinical Director Windrose Recovery: https://windroserecovery.com/

Integrata: www.integratahealing.com

Dr. Ingmar Gorman: https://www.ingmargorman.com/about

Lykos: https://lykospbc.com

  continue reading

35 episódios

Artwork
iconCompartilhar
 
Manage episode 425693814 series 2818467
Conteúdo fornecido por Windrose Recovery. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por Windrose Recovery ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.

Dr. Chantelle Thomas talks to Dr. Ingmar Gorman about concerns and methodological critiques of MDMA-assisted therapy, including historical boundary violations and inappropriate treatment of participants. They also address adverse event management, inner healing intelligence, and the importance of adapting language and approach to resonate with each individual participant. Additionally, they discuss the ethical complexities of conducting clinical trials, including balancing participant privacy and safety with the need to share information for public advocacy and education. Finally, they delve into the intricacies of trauma therapy, including personal experiences, clinical approaches, and limitations, and emphasize the need for a paradigm shift in clinical practice, prioritizing the client's agency and internal resources for healing.

(0:00:00) Introduction

(0:10:14) FDA's decision on MDMA therapy for PTSD, with focus on ICER and FDA advisory panel reports.

(0:15:21) The benefits and challenges of a clinical trial for treating PTSD.

(0:21:03) Conducting clinical trials with nuanced considerations for ethics, regulations, and participant experiences.

(0:31:52) Adverse events in the trial, with concerns about data accuracy and researcher bias.

(0:44:02) Suicidal ideation and its impact on mental health treatment.

(0:52:23) Clinical trial design and unblinding issues in PTSD treatment study.

(0:59:26) MDMA therapy for trauma, participants' experiences and criticisms.

(1:05:31) Trauma therapy effectiveness and the importance of considering other measures beyond PTSD symptoms.

(1:10:36) Inner healing intelligence in MDMA-assisted therapy.

(1:29:51) MDMA-assisted therapy for PTSD, including resourcing and adherence.

Dr. Chantelle Thomas, Executive Clinical Director Windrose Recovery: https://windroserecovery.com/

Integrata: www.integratahealing.com

Dr. Ingmar Gorman: https://www.ingmargorman.com/about

Lykos: https://lykospbc.com

  continue reading

35 episódios

Todos os episódios

×
 
Loading …

Bem vindo ao Player FM!

O Player FM procura na web por podcasts de alta qualidade para você curtir agora mesmo. É o melhor app de podcast e funciona no Android, iPhone e web. Inscreva-se para sincronizar as assinaturas entre os dispositivos.

 

Guia rápido de referências